AdVance™ XP

Established outcomes

• More than 9 years of clinical use¹
• More than 20,000 patients treated¹
• Demonstrated long-term success rates ranging from 76-89.4% at 3 years in patients with mild to moderate incontinence^2,3
• In patients with higher BMIs, AdVance XP sling has higher cure and improved rates over AdVance Sling⁴
  
• 25 studies, including more than 3,000 patients, have been reported in peer-reviewed literature

Patient benefits

• Minimally invasive procedure designed to allow most patients to resume normal, daily activities 1 -2 weeks post procedure⁵
• Patients may be continent immediately following their procedure⁶
• Patient manual dexterity and mental acuity are not criteria for exclusion⁶
• Can be used in combination with any penile prosthesis⁷
• If needed, the transition to an AMS 800™ Urinary Control System does not usually require mesh excision⁸